...ist has discovered key appetite control cells in t...ased hunger and potentially weight-gain as we grow...oendocrinologist with Monash University,s Departme..., Dr Andrews found that appetite-suppressing cell...aid the degeneration is more significant following...
... many men during their fight against prostate canc...searchers have found. The findings were published ...edings of the National Academy of Sciences . , Th...edeviled patients for decades. Hormone therapy, a ...ncer, generally keeps the cancer at bay for a year...
...s(TM) Wireless Data Communications Link School ..., WALL, N.J., Aug. 20 BIO-key International,Inc....sed biometric,identification and wireless public s...of MobileSRO(TM) and MobileCampus(TM), silent, sec...-12 schools and higher,education, respectively., ...
Other Biology News:Killer carbs -- Monash scientist finds the key to overeating as we age 2Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3(Date:11/24/2009)...re-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )...onsbytheU.S.BankruptcyCourtfortheDistrictofDelawar...tarypetitionfor,reliefunderChapter11oftheUnitedSta...heordersissuedbytheBankruptcyCourtallowthecompanyt...oceedings.Inparticular,the,companyreceivedinterimB...
(Date:11/24/2009)...proved the Promega PowerPlex 16 HS System for use ... records for the National DNA Index System. , ...e FBI recently approved the Promega PowerPlex®...ing in, or generating DNA records for, the Nationa... more than seven million profiles and has assisted...
(Date:11/24/2009)...FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )today...airman,willpresentatthe21stAnnualPiperJaffrayHealt...09at10:00a.m.ET. ,, Toaccesstheliveandsubsequen...orRelationssectionofGenomicHealth,swebsiteat http:...bsiteatleast15minutespriortothebeginningoftheprese...
(Date:11/23/2009)...ative new study, a University of Utah scientist ar...or cause of global warming cannot be stabilized u...lds the equivalent of one new nuclear power plant ...be any substantial near-term departure from recent...n rates," says the new paper by Tim Garrett, an as...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4.... 28 Beckman,Coulter, Inc. (NYSE: BEC ), announc...ents with Adventist Health to provide a broad rang...t approximately $36 million over,six years. Advent... care,system with facilities in California, Hawaii...scom.com/cgi-bin/prnh/20031202/BECLOGO ), Under t...
...um Drives 71% Year-Over-Year Growth in Core ... Calif., Oct. 28 Cepheid (Nasdaq:,CPHD) today rep....9,million, an increase of 24% over the third quar...$(0.11) per share, which compares to revenue of $3....09) per share, in the third,quarter of fiscal 200...
...ovavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vac...vi, President and Chief Executive Officer, will be... am. (PT) on October 30, 2008 at the,Palace Hotel ...vide an,overview of the company,s strategy, resear...esentation can be accessed via the Company website...
Other Biology Technology:Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-Human GMNN Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Normal Human Serum from 3H Biomedical AB
Biology Products: